HNN3.0
Register
Register
Register

Project cooperationUpdated on 18 February 2026

Working AI platform for medical device regulatory gap analysis — seeking IND-03 consortium

CEO at Klaris

London, United Kingdom

About

Most AI-for-regulatory proposals promise a platform that will be built during the project. We already have one in production.

Klaris AI is a London-based MedTech startup focused on one problem: medical device companies spend months and hundreds of thousands of euros on regulatory documentation that still comes back with gaps. Our platform uses AI trained on device-specific regulatory frameworks to automate gap analysis in technical documentation.

For a consortium targeting IND-03, we offer something specific: a working AI system that can serve as the testbed for validating improved regulatory methodologies and evidence frameworks across the device lifecycle. This means the consortium can demonstrate real-world applicability from day one rather than spending the first 18 months on platform development.

Topic

  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

Klaris

Start-up

London, United Kingdom

Similar opportunities

  • Project cooperation

    From Regulation to Practice: Translational Regulatory Science for Patient-Centred Health Technologies

    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

    Delphine Ribes Lemay

    Engineer/ Head of Group at EPFL+ECAL LAB

    Lausanne, Switzerland

  • Project cooperation

    REG-TRACE

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Fatih Eren

    R&D Incentive Management Specialist at İnnova IT Solutions

    Ankara, Türkiye

  • Project cooperation

    Advancing Single-Molecule De-Novo Protein Sequencing

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Til Schlotter

    ETH Researcher, Co-founder & CEO at UNOMR AG

    Zurich, Switzerland